Politiques de santé

Cnam 2027 Report: Deprescription as a Strategic Lever for Healthcare Savings

by

The French National Health Insurance fund, known as the Caisse nationale de l’Assurance maladie (Cnam), has officially identified “deprescribing” as a central strategy in its 2027 “Charges and Products” report to optimize pharmaceutical expenditure and improve patient safety. This initiative seeks to empower pharmacists to actively participate in the review and potential discontinuation of unnecessary … Read more

Covid-19 Vaccine Booster Campaign for Vulnerable Populations Faces Early Challenges Despite Rapid Launch

by

The spring Covid-19 vaccination renewal campaign targeting vulnerable populations in France began on April 20, 2026, and is scheduled to run through June 30, 2026, according to official government announcements. The initiative aims to provide enhanced protection ahead of the summer months for individuals at highest risk of severe disease, including older adults and immunocompromised … Read more

Type 2 Diabetes: Early Detection & Pharmacists’ Role in Risk Screening | France

by

Pharmacists Poised to Play Key Role in Early Diabetes Detection Millions across Europe remain undiagnosed with type 2 diabetes, a condition often detected only after the onset of serious complications. Now, a new report from French parliamentarians is advocating for a significant expansion of diabetes screening, with pharmacies positioned as a crucial access point for … Read more